Retrospective Iranian cohort links younger age and elevated ESR to relapse in pediatric Hodgkin lymphoma
A retrospective Iranian cohort of 83 children with Hodgkin lymphoma found treatment failure in 24, including 14 relapses, 11 cases ...
Tag: relapse
New Tools and Fresh Thinking Are Reshaping the Science of Addiction
A new Frontiers Research Topic argues that biosensors, longitudinal phenotyping, and transdiagnostic biomarkers are transforming addiction from a static label ...
HALT FEST: The Four-Letter Recovery Tool Gets a Contextual Upgrade
For decades, one of the most widely used tools in addiction recovery has been a four-word checklist so simple that ...
A Hidden RNA Splice Variant May Predict Relapse After CD19 CAR-T Therapy
Danish researchers report that low-level skipping of CD19 exon 2, detectable in pre-treatment RNA-sequencing data, correlates with relapse after anti-CD19 ...
Nearly $7 Million in New Grants Drive Hairy Cell Leukemia Research Forward
The Hairy Cell Leukemia Foundation and Blood Cancer United have announced six new research grants worth nearly $7 million to ...
Donor-Derived CD19 CAR-T Cells Deliver Lasting Remissions in Leukemia Patients After Transplant Failure
A Chinese clinical study reports that donor-derived anti-CD19 CAR-T cells achieved complete remissions in 13 of 14 patients whose B-cell ...
Steroids on Trial: Meta-Analysis Finds No Clear Benefit in Herpes Simplex Encephalitis
A new meta-analysis of randomized trials and observational studies finds no clear benefit or harm from adjunctive corticosteroids in herpes ...
Rare Thyroid Lymphoma Returns Six Years Later — and a New Drug Regimen Beats It Back
A new case report in the Annals of Hematology describes a woman whose rare primary thyroid diffuse large B-cell lymphoma ...
Hidden Leukemic Stem Cells That Fuel Relapse in FLT3-Mutated AML Finally Exposed
Researchers have functionally characterized CD34/CD123/CD25/CD99-positive leukemic progenitor cells in FLT3-ITD-mutated AML, showing they engraft and reinitiate leukemia in mice and ...
Stopping Ozanimod: Large Trial Follow-Up Finds Relapses Return Mildly, With No Sign of Rebound
A large post hoc analysis of the DAYBREAK trial found that only 3.3 percent of patients relapsed after stopping ozanimod, ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!